466: Hospitalization Days Due to Major Cardiac Events (MACE) in De Novo Heart Transplant Recipients: Data from a 12-Month, Multicenter, Randomized Trial of Everolimus Versus MMF

H. Lehmkuhl; J. Arizon; L. Almenar; C. Magelli; G. Gerosa; S. Varnous; F. Musumeci; M.-F. Mattei; J. Vanhaecke; K. Mange; G. Machnicki

doi:10.1016/j.healun.2007.11.479

466: Hospitalization Days Due to Major Cardiac Events (MACE) in De Novo Heart Transplant Recipients: Data from a 12-Month, Multicenter, Randomized Trial of Everolimus Versus MMF

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2007.11.479 ◽

2008 ◽

Vol 27 (2) ◽

pp. S228 ◽

Cited By ~ 2

Author(s):

H. Lehmkuhl ◽

J. Arizon ◽

L. Almenar ◽

C. Magelli ◽

G. Gerosa ◽

...

Keyword(s):

Randomized Trial ◽

Heart Transplant ◽

De Novo ◽

Transplant Recipients ◽

Cardiac Events ◽

Multicenter Randomized Trial ◽

Heart Transplant Recipients

Download Full-text

DECREASE OF MAJOR CARDIAC EVENTS AND HOSPITALIZATIONS IN DE NOVO HEART TRANSPLANT RECIPIENTS RECEIVING EVEROLIMUS: RESULTS FROM A 12-MONTH, MULTICENTER, RANDOMIZED TRIAL COMPARING EVEROLIMUS WITH MMF

Transplantation Journal ◽

10.1097/01.tp.0000332064.44238.d2 ◽

2008 ◽

Vol 86 (Supplement) ◽

pp. 240

Author(s):

H Lehmkuhl ◽

J Arizon ◽

L Almenar ◽

C Magelli ◽

G Gerosa ◽

...

Keyword(s):

Randomized Trial ◽

Heart Transplant ◽

De Novo ◽

Transplant Recipients ◽

Cardiac Events ◽

Multicenter Randomized Trial ◽

Heart Transplant Recipients

Download Full-text

Major cardiac events (MACE) and their impact on hospitalization days in de novo heart transplant recipients on everolimus versus MMF

The Thoracic and Cardiovascular Surgeon ◽

10.1055/s-0029-1247079 ◽

2010 ◽

Vol 58 (S 01) ◽

Author(s):

H Lehmkuhl ◽

T Dengler ◽

G Maccherini ◽

S Scheidl ◽

R Hetzer

Keyword(s):

Heart Transplant ◽

De Novo ◽

Transplant Recipients ◽

Cardiac Events ◽

Heart Transplant Recipients

Download Full-text

Prograf decreases plasma cholesterol in heart transplant recipients with treated but persisting mild dyslipidemia: the canadian multicenter randomized trial of prograf versus neoral

The Journal of Heart and Lung Transplantation ◽

10.1016/s1053-2498(02)00900-2 ◽

2003 ◽

Vol 22 (1) ◽

pp. S140 ◽

Cited By ~ 1

Author(s):

Michel White

Keyword(s):

Randomized Trial ◽

Heart Transplant ◽

Plasma Cholesterol ◽

Transplant Recipients ◽

Multicenter Randomized Trial ◽

Heart Transplant Recipients

Download Full-text

Prograf decreases plasma cholesterol in heart transplant recipients with treated but persisting mild dyslipidemia: The Canadian multicenter randomized trial of prograf versus neoral

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(03)82359-8 ◽

2003 ◽

Vol 41 (6) ◽

pp. 289-290

Author(s):

Michel White

Keyword(s):

Randomized Trial ◽

Heart Transplant ◽

Plasma Cholesterol ◽

Transplant Recipients ◽

Multicenter Randomized Trial ◽

Heart Transplant Recipients

Download Full-text

Rad in combination with cyclosporine a in de novo heart transplant recipients: A two-year multicenter study to investigate the prevention of graft rejection and vasculopathy

The Thoracic and Cardiovascular Surgeon ◽

10.1055/s-2004-816685 ◽

2004 ◽

Vol 52 (S 1) ◽

Author(s):

H Lehmkuhl ◽

R Hetzer ◽

M Hummel ◽

A Haverich ◽

M Sch�ffer ◽

...

Keyword(s):

Cyclosporine A ◽

Heart Transplant ◽

Multicenter Study ◽

Graft Rejection ◽

De Novo ◽

Transplant Recipients ◽

Heart Transplant Recipients

Download Full-text

Single-centre first experience with everolimus and CSA for de novo heart transplant recipients

The Thoracic and Cardiovascular Surgeon ◽

10.1055/s-2005-922342 ◽

2005 ◽

Vol 53 (S 3) ◽

Author(s):

H Lehmkuhl ◽

M Dandel ◽

C Knosalla ◽

O Grauhan ◽

M Jurmann ◽

...

Keyword(s):

Heart Transplant ◽

De Novo ◽

Transplant Recipients ◽

Single Centre ◽

Heart Transplant Recipients

Download Full-text

Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV- seropositive heart transplant recipients treated with OKT3

Antimicrobial Agents and Chemotherapy ◽

10.1128/aac.39.7.1643 ◽

1995 ◽

Vol 39 (7) ◽

pp. 1643-1645 ◽

Cited By ~ 29

Author(s):

J. M. Aguado ◽

M. A. Gomez-Sanchez ◽

C. Lumbreras ◽

J. Delgado ◽

M. Lizasoain ◽

...

Keyword(s):

Randomized Trial ◽

Heart Transplant ◽

Prospective Randomized Trial ◽

Transplant Recipients ◽

Heart Transplant Recipients ◽

Cmv Disease

Download Full-text

Everolimus Initiation With Calcineurin Inhibitor Withdrawal Reduces Allograft Vasculopathy in De-Novo Heart Transplant Recipients

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2014.01.412 ◽

2014 ◽

Vol 33 (4) ◽

pp. S154 ◽

Cited By ~ 2

Author(s):

S. Arora ◽

B. Andersson ◽

F. Gustafsson ◽

H. Eiskjær ◽

G. Rådegran ◽

...

Keyword(s):

Heart Transplant ◽

Calcineurin Inhibitor ◽

De Novo ◽

Transplant Recipients ◽

Allograft Vasculopathy ◽

Heart Transplant Recipients

Download Full-text

Cardiac Allograft Vasculopathy: Differences in De Novo and Maintenance Heart Transplant Recipients

Transplantation Journal ◽

10.1097/01.tp.0000243150.89762.fc ◽

2006 ◽

Vol 82 (Supplement) ◽

pp. S5-S12 ◽

Cited By ~ 5

Author(s):

Maria Frigerio ◽

Andrea Garascia ◽

Elena Roubina ◽

Giada Distefano ◽

Pedro Silva Orrego ◽

...

Keyword(s):

Heart Transplant ◽

De Novo ◽

Cardiac Allograft Vasculopathy ◽

Cardiac Allograft ◽

Transplant Recipients ◽

Allograft Vasculopathy ◽

Heart Transplant Recipients

Download Full-text

Late Antibody-Mediated Rejection Due To De-Novo Donor-Specific Anti-HLA Antibodies in Heart Transplant Recipients: A Cohort of 20 Consecutive Patients

The Journal of Heart and Lung Transplantation ◽

10.1016/j.healun.2014.01.481 ◽

2014 ◽

Vol 33 (4) ◽

pp. S178

Author(s):

G. Coutance ◽

S. Ouldamar ◽

P. Rouvier ◽

C. Suberbielle ◽

S. Saheb ◽

...

Keyword(s):

Heart Transplant ◽

De Novo ◽

Transplant Recipients ◽

Hla Antibodies ◽

Antibody Mediated Rejection ◽

Heart Transplant Recipients

Download Full-text